Related Experiment Video
Updated: Jul 17, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Mixed intestinal protozoal infection masquerading as ulcerative colitis in advanced AIDS: a case report
Yan Zhang1, Xiaojin Ding2, Jing Gao3
1Department of Clinical Laboratory, Hangzhou Xixi Hospital, Hangzhou Sixth People's Hospital, Hangzhou, Zhejiang, China.
None:
Co-infection with Entamoeba histolytica (E. histolytica) and Giardia lamblia (G. lamblia) is exceptionally rare reported in individuals with human immunodeficiency virus (HIV), despite both protozoa being well-recognized etiologic agents of intestinal disease in the general population. The overlapping clinical manifestations of protozoal infections and inflammatory bowel disease may pose significant diagnostic challenges, particularly in patients with advanced immunosuppression. We report the case of a 34-year-old man with advanced acquired immunodeficiency syndrome (AIDS) who presented with persistent mucopurulent bloody stools for 2 months. Upon evaluation in our gastroenterology department, ulcerative colitis was initially considered; however, stool microscopy subsequently identified trophozoites of E. histolytica and G. lamblia. Colonoscopic assessment, supported by histopathological examination of biopsy specimens, confirmed E. histolytica infection. The patient was initiated on intravenous metronidazole in conjunction with antiretroviral therapy, leading to a gradual improvement of symptoms, with resolution of diarrhea within 10 days. This case highlights the importance of considering mixed protozoal infections in the differential diagnosis of chronic dysentery among immunocompromised patients. It further underscores the critical diagnostic value of repeated stool microscopy and histopathologic confirmation to avoid misdiagnosis and prevent delays in appropriate therapy.
Related Concept Videos
Amebiasis
Giardiasis
Inflammatory Bowel Disease II: Ulcerative Colitis
Cryptococcal Meningitis
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...